Inicio › Cáncer de páncreas › Utah
Ensayos clínicos de Cáncer de páncreas en Utah
27 estudios sobre Cáncer de páncreas buscan participantes en Utah.
Ciudades en Utah
Texto oficial del estudio (inglés)
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07491445A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Mountain Region, LLC, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- University of Utah, Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07252232A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Utah Cancer Specialists, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07409272A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US053, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07522073Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06445062Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoEstudio observacional
Edades de 50 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT04239573A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06400472A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Utah - Huntsman Cancer Institute, Salt Lake City
- START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06465069A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- START- Mountain Region, West Valley City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07644559A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT06242470Pancreatic Cancer Early Detection Consortium
- Huntsman Cancer Institute, Salt Lake City
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 90 · Todos los sexos · Actualizado el 22 jul 2026 · NCT04970056A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT07300150A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT07458347Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Start Mountain Region /ID# 276270, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT05005403A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 may 2026 · NCT07223047Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 may 2026 · NCT05379985Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT05297734A Study of MGC028 in Participants With Advanced Solid Tumors
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 abr 2026 · NCT06723236A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 abr 2026 · NCT07020221A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 mar 2026 · NCT06244771Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT07030257A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University Telemedicine, Cedar City
- Ohio State University-Telemedicine, Salt Lake City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT06906562Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT07145255JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
- Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 ene 2026 · NCT06973564VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Utah Cancer Specialists (site 203), Salt Lake City
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 dic 2025 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.